Trial Profile
A Phase III trial of Cibinetide sarcoidosis-related small fiber neuropathy
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 05 Apr 2018
Price :
$35
*
At a glance
- Drugs Cibinetide (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 05 Apr 2018 New trial record